Early research (Phase 1)Study completedNCT01431170
What this trial is testing
Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children
Who this might be right for
Congenital Nasolacrimal Duct Obstruction
Rutgers, The State University of New Jersey 24